Number of the records: 1
DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities
Title DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities Author Jurkovičová Dana 1973- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV ORCID Co-authors Neophytou Christiana M. Čipak Ana Gonçalves Ana Cristina Source document International Journal of Molecular Sciences. Vol. 23 (2022), art. no. 14672 Language eng - English Country CH - Switzerland Note open access URL URL link Document kind rozpis článkov z periodík (rbx) Citations MAHUMUD, R.A. - SHAHJALAL, M. The Emerging Burden of Genetic Instability and Mutation in Melanoma: Role of Molecular Mechanisms. In CANCERS. DEC 2022, vol. 14, no. 24. Dostupné na: https://doi.org/10.3390/cancers14246202. GAO, A.A.I. - BAI, P.P. - ZHANG, M.Y. - YAO, Y.X. - HERMAN, J.G. - GUO, M.Z. RASSF1A promotes ATM signaling and iRASSF1A/i methylation is a synthetic lethal marker for ATR inhibitors. In EPIGENOMICS. ISSN 1750-1911, 2023 DEC 14 2023. Dostupné na: https://doi.org/10.2217/epi-2023-0306. NICKOLOFF, J.A. - JAISWAL, A.S. - SHARMA, N. - WILLIAMSON, E.A. - TRAN, M.T. - ARRIS, D. - YANG, M. - HROMAS, R. Cellular Responses to Widespread DNA Replication Stress. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. ISSN 1661-6596, DEC 2023, vol. 24, no. 23. Dostupné na: https://doi.org/10.3390/ijms242316903. GONNELLA, R. - ZARRELLA, R. - DI CROSTA, M. - BENEDETTI, R. - ARENA, A. - SANTARELLI, R. - MONTANI, M.S.G. - D'ORAZI, G. - CIRONE, M. HSP110 Inhibition in Primary Effusion Lymphoma Cells: One Molecule, Many Pro-Survival Targets. In CANCERS. DEC 2023, vol. 15, no. 23. Dostupné na: https://doi.org/10.3390/cancers15235651. RISMANBAF, A. Improving targeted small molecule drugs to overcome chemotherapy resistance. In CANCER REPORTS. JAN 2024, vol. 7, no. 1. Dostupné na: https://doi.org/10.1002/cnr2.1945. LI, Y.P. - LI, X.Q. - YANG, Y.F. - QIAO, X.H. - TAO, Q. - PENG, C. - HAN, M. - DONG, K.B. - XU, M. - WANG, D.Q. - HAN, G.H. Association of genes in hereditary metabolic diseases with diagnosis, prognosis, and treatment outcomes in gastric cancer. In FRONTIERS IN IMMUNOLOGY. ISSN 1664-3224, NOV 9 2023, vol. 14. Dostupné na: https://doi.org/10.3389/fimmu.2023.1289700. CHEN, H.J. - HU, Y.C. - ZHUANG, Z.R. - WANG, D.Y. - YE, Z. - JING, J. - CHENG, X.D. Advancements and Obstacles of PARP Inhibitors in Gastric Cancer. In CANCERS. NOV 2023, vol. 15, no. 21. Dostupné na: https://doi.org/10.3390/cancers15215114. ANDRéS, C.M.C. - DE LA LASTRA, J.M.P. - JUAN, C.A. - PLOU, F.J. - PéREZ-LEBEñA, E. Chemical Insights into Oxidative and Nitrative Modifications of DNA. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. ISSN 1661-6596, OCT 2023, vol. 24, no. 20. Dostupné na: https://doi.org/10.3390/ijms242015240. KLONISCH, T. - LOGUE, S.E. - HOMBACH-KLONISCH, S. - VRIEND, J. DUBing Primary Tumors of the Central Nervous System: Regulatory Roles of Deubiquitinases. In BIOMOLECULES. OCT 2023, vol. 13, no. 10. Dostupné na: https://doi.org/10.3390/biom13101503. GULLIVER, C. - HUSS, S. - SEMJONOW, A. - BAILLIE, G.S. - HOFFMANN, R. Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategies. In BRITISH JOURNAL OF CANCER. ISSN 0007-0920, OCT 26 2023, vol. 129, no. 9, p. 1462-1476. Dostupné na: https://doi.org/10.1038/s41416-023-02417-5. BHATTACHARJEE, B. - SYEDA, A.F. - RYNJAH, D. - HUSSAIN, S.M. - BORA, S.C. - PEGU, P. - SAHU, R.K. - KHAN, J. Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment. In FRONTIERS IN PHARMACOLOGY. MAY 3 2023, vol. 14. Dostupné na: https://doi.org/10.3389/fphar.2023.1174330. PAN, M.A. - SHA, Y. - QIU, J.G. - CHEN, Y.M. - LIU, L.L. - LUO, M.Y. - HUANG, A.L. - XIA, J. RAD51 Inhibition Shows Antitumor Activity in Hepatocellular Carcinoma. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. ISSN 1661-6596, APR 26 2023, vol. 24, no. 9. Dostupné na: https://doi.org/10.3390/ijms24097905. NJENGA, L.W. - MBUGUA, S.N. - ODHIAMBO, R.A. - ONANI, M.O. Addressing the gaps in homeostatic mechanisms of copper and copper dithiocarbamate complexes in cancer therapy: a shift from classical platinum-drug mechanisms. In DALTON TRANSACTIONS. ISSN 1477-9226, MAY 9 2023, vol. 52, no. 18, p. 5823-5847. Dostupné na: https://doi.org/10.1039/d3dt00366c. TAO, L. - ZHOU, K.H. - ZHAO, Y. - XIA, X.Y. - GUO, Y.J. - GAO, Y. - PENG, G.P. - LIU, Y.Q. Betulinic acid, a major therapeutic triterpene of Celastrus orbiculatus Thunb., acts as a chemosensitizer of gemcitabine by promoting Chk1 degradation. In JOURNAL OF ETHNOPHARMACOLOGY. ISSN 0378-8741, JUN 12 2023, vol. 309. Dostupné na: https://doi.org/10.1016/j.jep.2023.116295. Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2022 Registered in WOS Registered in SCOPUS Registered in CCC DOI 10.3390/ijms232314672 
article
File name Access Size Downloaded Type License DNA Damage Response in Cancer Therapy and Resistancechallenges and Opportunities.pdf available 673 KB 3 Publisher's version rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2022 2021 6.208 Q1 1.176 Q1
Number of the records: 1